Promoting Informed Choice for Breast Cancer Screening

Completed · Phase 2

Conditions studied: Breast Cancer

In brief

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

Key facts

Study ID

NCT05376241

Run by

University of Colorado, Denver

People needed

637

Starts

2022-01-03

Expected to finish

2022-05-07

Last updated by the study team

2026-03-27

Who can join

Age: 39 and older, up to 49. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female
• Between 39-49 years of age
• No history of breast cancer
• No known BRCA 1/2 mutation

You may not qualify if…

• Non-English or Spanish Speaking
• Persons unable to provide informed consent (e.g. sever dementia or cognitive disability or illiterate
• History of breast cancer
• Known BRCA 1/2 mutation

Where it is running

• University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.